Elvira Coniglio

Dr. Elvira Coniglio


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DBDesiree Brancato
Desiree Brancato
Simone TreccarichiSimone Treccarichi
Simone Treccarichi
FBFrancesca Bruno
Francesca Bruno
ECElvira Coniglio
Elvira Coniglio
MVMirella Vinci
Mirella Vinci
Concetta FedericoConcetta Federico
Concetta Federico
Next-Generation Sequencing (NGS) techniques have become a cornerstone of molecular diagnostics, enabling high-throughput, parallel analysis of multiple disease-associated genes. Their targeted design allows streamlined interpretation and optimised diagnostic yield, especially in disorders with known genetic heterogeneity. In this review, we provide a comprehensive overview of the clinical application of NGS techniques—targeted gene panels, whole exome sequencing (WES) and whole genome sequencing (WGS)—detailing the methodological workflow and the critical steps involved in their implementation. Particular emphasis is placed on the genes identified through NGS that are implicated in neurodevelopmental, neurodegenerative, psychiatric, neuromuscular, cardiovascular, and metabolic disorders. We also compare the advantages and limitations of panel-based diagnostics versus WES and WGS, and discuss future directions, including the integration of long-read sequencing technologies into multidisciplinary clinical practice. Finally, we consider how these advances may ultimately bridge biomedical research and clinical practise to improve the diagnosis and management of multifactorial diseases.

12 June 2025 in Genes
Verified
Journal Article
Open access
PDF file
Salvatore SacconeSalvatore Saccone
Salvatore Saccone
DBDesiree Brancato
Desiree Brancato
FBFrancesca Bruno
Francesca Bruno
ECElvira Coniglio
Elvira Coniglio
VSValentina Sturiale
Valentina Sturiale
Concetta FedericoConcetta Federico
Concetta Federico
The origin and evolution of genes are central themes in evolutionary biology and genomics, shedding light on how molecular innovations shape biological complexity and adaptation. This review explores the principal mechanisms underlying gene emergence in eukaryotes, including gene duplication, de novo gene birth, horizontal gene transfer, viral gene domestication, and exon shuffling. We examine the population dynamics that govern the fixation of new genes, their functional integration, and the selective forces acting upon them—from purifying selection to adaptive innovation. Examples such as NOTCH2NL and SRGAP2C, which originated through recent segmental duplications followed by neofunctionalization, illustrate how duplicate-derived de novo genes can play a key role in human brain development. In addition, we highlight the emerging relevance of nuclear architecture in determining the evolutionary fate of new genes, offering a spatial dimension to gene innovation. We also discuss methodological approaches for detecting new genes and inferring selection, and finally, we highlight the emerging role of the human pangenome in revealing hidden gene diversity and its implications for evolutionary and biomedical research. Understanding gene innovation not only enhances our grasp of evolutionary processes but also informs clinical studies on disease susceptibility and human uniqueness.

30 June 2025 in Genes
Verified
Journal Article
Open access
PDF file
Concetta FedericoConcetta Federico
Concetta Federico
DBDesiree Brancato
Desiree Brancato
FBFrancesca Bruno
Francesca Bruno
ECElvira Coniglio
Elvira Coniglio
VSValentina Sturiale
Valentina Sturiale
Salvatore SacconeSalvatore Saccone
Salvatore Saccone
The spatial organization of the genome within the nucleus is a fundamental regulator of gene expression, genome stability, and cell identity. This review addresses the central question of how nuclear genome architecture contributes to disease mechanisms and diagnostics, and how technological advances enable its clinical exploration. We first outline the principles of nuclear genome architecture, including chromosome territories, replication timing, and 3D domains, and their role in gene regulation and disease. We then explore the mechanisms and consequences of chromosomal rearrangements, and how replication dynamics intersect with epigenetic regulation and genome stability. Diagnostic tools are presented in chronological progression, from conventional cytogenetics to high-resolution genomic and single-cell techniques. A dedicated section focuses on cancer cytogenomics and its clinical implications. We further highlight emerging technologies for 3D genome and epigenome profiling and their integration into diagnostic workflows. Finally, we discuss current challenges, such as standardization and cost, and the transformative potential of multi-omics and artificial intelligence for future precision diagnostics. Overall, we provide a comprehensive overview of how cytogenetics and cytogenomics contribute to the understanding and clinical diagnosis of genetic and neoplastic diseases.

18 May 2026 in Genes
Verified
Journal Article
Open access
PDF file
DBDesiree Brancato
Desiree Brancato
ECElvira Coniglio
Elvira Coniglio
FBFrancesca Bruno
Francesca Bruno
Simone TreccarichiSimone Treccarichi
Simone Treccarichi
MVMirella Vinci
Mirella Vinci
Concetta FedericoConcetta Federico
Concetta Federico
Recent advances in forensic genetics are rapidly transforming the field from traditional DNA profiling toward integrative and predictive genomic approaches. While short tandem repeat (STR)-based typing remains the gold standard for human identification, emerging technologies such as massively parallel sequencing (MPS), forensic genetic genealogy (FGG), and artificial intelligence (AI)-driven bioinformatics are expanding the scope of forensic investigations, with MPS also widely established in clinical genomics, further supporting its application in complex and unresolved cases. This article presents a structured narrative and conceptual review of next-generation forensic genomics, based on selected peer-reviewed studies, technical guidelines, and recent review articles relevant to MPS-based marker analysis, FGG, DNA phenotyping, ancestry inference, AI-supported bioinformatics, validation, and ethical/legal issues. We discuss the transition from STRs to single nucleotide polymorphisms (SNPs) and microhaplotypes enabled by MPS, emphasizing their applications in mixture deconvolution, kinship analysis, and degraded DNA samples. The role of FGG in cold case resolution is examined, alongside methodological, legal, and ethical considerations related to the use of public genetic databases. Furthermore, we explore recent developments in DNA phenotyping and ancestry inference, focusing on predictive models of externally visible characteristics (EVCs) and their forensic utility. Particular attention is given to the growing impact of AI and machine learning in data interpretation, probabilistic genotyping, and pattern recognition across complex genomic datasets. Finally, we address current limitations, including technical standardization, population biases, data privacy concerns, and the need for robust validation frameworks. Rather than providing a systematic review, this work aims to synthesize current developments into an operational framework for integrated forensic genomics, distinguishing forensic intelligence, probabilistic interpretation, confirmatory testing, and evidentiary use. By integrating technological, analytical, and ethical perspectives, this review proposes a conceptual framework for integrated forensic genomics, in which genomic data are used not only for identification but also for forensic intelligence generation.

Verified
Journal Article
Open access
PDF file
DBDesiree Brancato
Desiree Brancato
AMAgnese Messina
Agnese Messina
OLOscar Lisi
Oscar Lisi
FBFrancesca Bruno
Francesca Bruno
ECElvira Coniglio
Elvira Coniglio
Concetta FedericoConcetta Federico
Concetta Federico
Sergentomyia minuta is a widespread Mediterranean sand fly traditionally regarded as herpetophilic and of limited relevance for human leishmaniasis. Occasional detection of mammalian Leishmania DNA in Sergentomyia species has challenged this assumption. This study aimed to investigate the abundance, host-feeding behaviour, and molecular detection of Leishmania infantum DNA in S. minuta in peri-urban areas of southern Italy. Sand flies were collected using sticky traps at three sites in the Catania area (Italy). Unengorged females were screened for Leishmania spp. DNA using ITS1 and SSU rRNA markers. ITS1 PCR-RFLP was used exclusively to discriminate L. infantum-compatible from non-L. infantum molecular profiles. Engorged females were analysed for blood-meal origin using mitochondrial cytochrome b markers (CytB1 and CytB2) and a nuclear human-specific transthyretin (TTR) marker through PCR-RFLP and multiplex PCR. A total of 1361 S. minuta specimens were collected, with a strongly female-biased sex ratio. Leishmania spp. DNA was detected in a substantial proportion of pooled samples. ITS1 PCR-RFLP profiles revealed heterogeneous molecular patterns that consistently excluded L. infantum and were compatible with non-L. infantum trypanosomatid DNA. Blood-meal analyses suggested feeding on multiple vertebrate hosts, including occasional detection of human mitochondrial DNA, whereas the nuclear TTR marker was consistently negative, likely reflecting DNA degradation during blood digestion. S. minuta populations from southern Italy display high abundance, ecological plasticity, and a strong association with peri-urban habitats. Our findings refine, rather than overturn, the current understanding of the epidemiological role of S. minuta in Mediterranean ecosystems. Multilocus molecular screening revealed heterogeneous non-L. infantum trypanosomatid DNA patterns, while no evidence of Leishmania infantum was detected. Occasional human blood meals were detected, but the epidemiological relevance of S. minuta for human leishmaniasis remains unproven. These findings highlight the importance of integrated entomological and molecular approaches for careful interpretation of vector–parasite–host relationships Mediterranean ecosystems.

23 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
Salvatore SacconeSalvatore Saccone
Salvatore Saccone
FBFrancesca Bruno
Francesca Bruno
DBDesiree Brancato
Desiree Brancato
ECElvira Coniglio
Elvira Coniglio
VSValentina Sturiale
Valentina Sturiale
Concetta FedericoConcetta Federico
Concetta Federico
Nutrigenetics and nutrigenomics represent complementary dimensions of the complex relationship between diet and the human genome and provide a conceptual basis for precision nutrition. Nutrigenetics investigates how interindividual genetic variability influences food perception, dietary behavior, nutrient metabolism, and biological responses, whereas nutrigenomics explores how nutrients and bioactive food components modulate gene expression, signaling pathways, and epigenetic mechanisms. Importantly, these processes are interconnected: genetic variation may influence dietary exposure itself through effects on sensory perception, food preferences, appetite, and eating behavior, while additional genetic differences can modify nutrient absorption, metabolism, bioavailability, and downstream molecular responses. This review integrates these interactions within a diet–genome–phenotype framework, incorporating nutrient-responsive molecular pathways, epigenetic regulation, and the gut microbiota as additional determinants of interindividual variability. Overweight and obesity are examined as a paradigmatic application of this framework, illustrating how genetic determinants of dietary exposure and metabolic response may jointly contribute to susceptibility and heterogeneous responses to nutritional interventions. We further propose a research-oriented Weighted Evidence Score (WES) for the evidence-based prioritization of candidate genetic variants, integrating seven domains of functional evidence, phenotypic evidence, independent replication, genotype–diet interactions, nutritional intervention evidence, incremental predictive value, and population validity. In a pilot application to twelve illustrative variants or haplotypes, eight were classified as Tier 2 and four as Tier 3, with none meeting the requirements for Tier 1. Rather than representing an immediately actionable clinical test, such a research-oriented panel is intended as a dynamic hypothesis-generating and validation tool integrating genotype with dietary exposure, metabolic and molecular biomarkers, lifestyle factors, and phenotypic outcomes. Particular emphasis is placed on distinguishing evidence-based research prioritization from the additional validation required for clinical actionability. Finally, ethical, professional, and social challenges related to genomic information, including informed consent, privacy, communication, population diversity, and equitable implementation, are considered. Precision nutrition should ultimately be defined not by the amount of molecular information collected, but by its demonstrated ability to provide incremental predictive value and improve nutritional interventions beyond what can be achieved using established clinical, dietary, and population-based approaches.